PowerTalk: A Profitable Diagnosis on Health-care Investing

Chris Versace

Chris Versace is a financial columnist and equity analyst with more than 20 years of experience in the investment industry.

Investing can be fun and profitable at times, but it also can be tricky. There are hundreds, if not thousands, of companies to choose from in dozens and dozens of industries. Some are new and thriving like wireless, broadband and social media. That’s great for companies like Qualcomm (QCOM), Entropic (ENTR) and Facebook (FB), as well as their shareholders. Others like newspapers such as the New York Times (NYT), book publishers and retail book stores like Barnes & Noble (BKS) are feeling the pain as their industries adapt to what I call the Always On, Always Connected society.

The economy and industry fundamentals are not the only thing to watch and listen to with your investing eyes and ears. One other aspect is the regulatory environment and more specifically new regulations. As we know, business has been saddled with a number of them over the last few years, but none have the ability to impact the cost structure of a business like the Affordable Care Act, which is more commonly known as Obamacare.

We’ve done a few PowerTalks already that have looked at the implications of Obamacare and other regulations. This week, we’re talking about how you can profit from these regulations.

Joining me this week on PowerTalk are George Abraham and Sumesh Sood of Veda Healthcare Partners. Veda is a hedge fund that has been in operation for more than two and a half years and invests in healthcare. From biotech and pharmaceuticals to managed care and generic drugs, these guys are looking at all of it with an eye toward delivering profits for their investors.

Exclusive  Vodafone Looks to Unload Verizon Wireless for $130 Billion; Pump-and-Dump Stocks Hit Medical Marijuana; Spreadsheet Is Smoking Gun in JPMorgan Probe

Health-care investing can be a tricky thing, but when we look around and see just the shifting demographics — living longer, a heavier population, nutritional concerns and more — it’s apparent that there are a number of pain points. For me, pain points mean opportunity for the prepared investor. Let’s listen to what George and Sumesh see as remedies for not only these issues but also for your wallet.

Listen to my behind-the-scenes PowerTalk conversation now, so you are even more in the know:

Special introductory offer: Right now you can try Chris Versace’s PowerTrend Profits risk-free for only $99.95! Find out how, here.

Access prior PowerTalk interviews here:

Rolling in the Dough, CEO of Panera Bread Finds Profitable Recipe

Navigating the Airways with BlackJet CEO Dean Rotchin

Abe’s Market — More than the Intersection of Amazon.com and Whole Foods

What You Need to Know as the Fed Gets Ready to Taper its Stimulus: Advice from Experts Douglas Holtz-Eakin and Diana Furchtgott-Roth

Sizing up Cyber Security with Sourcefire (FIRE) CTO and Founder Martin Roesch

Like This Article?
Now Get Mark's FREE Special Report:
3 Dividend Plays with Sky-High Returns

This newly-released report by a top-20 living economist details three investments that are your best bets for income and appreciation for the rest of the year and beyond.

Get Access to the Report, 100% FREE


img
previous article

With the Stratasys (SSYS) share price popping 3.08% yesterday, the stock is now up 13.69% since my initial recommendation. Raise your stop to $92.10 to lock in at least a 10% gain in the stock. With the September $85 calls (SSYS130921C00085000) up 59.55%, sell half of your options here to lock in some nice double-digit percentage gains. In addition, with Nov 2013 Delphi $52.50 calls (

PREMIUM SERVICES FOR INVESTORS

Dr. Mark Skousen

Named one of the "Top 20 Living Economists," Dr. Skousen is a professional economist, investment expert, university professor, and author of more than 25 books.

Product Details

LEARN MORE HERE

Bryan Perry

A former Wall Street financial advisor with three decades' experience, Bryan Perry focuses his efforts on high-yield income investing and quick-hitting options plays.

Product Details

LEARN MORE HERE

Jim Woods

Jim Woods has over 20 years of experience in the markets from working as a stockbroker,
financial journalist, and money manager. As well as a book author and regular contributor to
numerous investment websites, Jim is the editor of:

Product Details

LEARN MORE HERE

Bob Carlson

Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.

Product Details

LEARN MORE HERE

Mike Turner

Mike Turner’s financial, mathematical, computer science and engineering background serves as the foundation for his disciplined, rules-based approach to trading. Mike’s three services include:

Product Details

LEARN MORE HERE

Hilary Kramer

Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. Since 2010, Hilary's financial publications have provided stock analysis and investment advice to her subscribers:

Product Details

LEARN MORE HERE

DividendInvestor.com

Used by financial advisors and individual investors all over the world, DividendInvestor.com is the premier provider and one-stop shop for dividend information and research.

Product Details

Popular tools include our proprietary Dividend Calendar, Dividend Calculator, Dividend Score Card, and many more.

LEARN MORE HERE